An expert said weight loss drugs might help people see faster results, which can give them encouragement to continue. But he ...

Eli Lilly added to gains, amid a sense that the maker of Mounjaro and Zepbound is pulling away from its competition in the obesity-drug boom. Shares of Novo Nordisk, the Danish maker of Ozempic and ...

Pfizer said on Friday it had filed a lawsuit against Metsera and Novo Nordisk , saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker's $8. obesity drug developer ...

As of Wednesday, when the stock rose 3%, Nvidia was larger than Qualcomm, AMD, Arm Holdings, ASML, Broadcom, Intel, Lam ...

Amy Schumer seems to be feeling herself after losing weight. The comedian — who has admitted to using weight loss drugs to ...

Amy Schumer feels "so grateful" to be pain free. The Life and Beth actress - who has six-year-old son Gene with husband Chris ...

A woman has revealed why she's changed over to Mounjaro from Ozempic as part of her weight loss journey. People have been ...

Plus, the Trump administration is expected to release finalized Medicare payment rules for doctors and hospitals as soon as ...

Wegovy Zepbound cost-effectiveness report finds both drugs remain valuable at higher prices despite affordability concerns, per ICER analysis.

For many, losing weight through diet, exercise and lifestyle changes alone can be frustratingly limited. Today, GLP-1 ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.

Elizabeth Zinni, owner of the Zinni Family Practice in Canfield, was indicted on two counts of sale or use of drugs not ...